Skip to main content Skip to section navigation Skip to footer
ProMIS Neurosciences, Inc.
  • Home
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Business Advisory Board
  • Our Science
  • Product Pipeline
    • Overview
    • Alzheimer’s Disease
    • ALS
    • MSA
    • Parkinson’s Disease
    • Posters & Publications
  • News & Media
    • Press Releases
    • Corporate Presentations
    • Events
    • In The News
    • Videos
    • Commentary
    • Podcasts
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Results
    • Stock Data
    • SEDAR
    • SEC Filings
    • Governance
  • Careers
  • Contact

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Results
  • Stock Data
    • TSX: PMN
    • NASDAQ: PMN
    • Analyst Coverage
  • SEDAR
  • SEC Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Oct 17, 2019 7:30am EDT

ProMIS Neurosciences advances Alzheimer's disease program targeting neurotoxic forms of tau

Oct 08, 2019 7:30am EDT

ProMIS Neurosciences Identifies Novel Antibody Candidates for Multiple System Atrophy

Sep 16, 2019 7:30am EDT

ProMIS Neurosciences Executive Chairman Eugene Williams to Speak on Panel at Fall Investor Summit

Sep 03, 2019 7:30am EDT

ProMIS Neurosciences to Present at H.C. Wainwright Investor Conference

Sep 03, 2019 7:30am EDT

ProMIS Neurosciences to Present at HC Wainwright Investment Conference

Aug 27, 2019 7:30am EDT

ProMIS Neurosciences Appoints Internationally Recognized Researcher in Alzheimer’s Disease in Down Syndrome Dr. Andre Strydom to its Scientific Advisory Board

Aug 27, 2019 7:30am EDT

ProMIS Neurosciences Appoints Internationally Recognized Researcher in Alzheimer's Disease in Down Syndrome Dr. Andre Strydom to its Scientific Advisory Board

Aug 13, 2019 7:30am EDT

ProMIS Neurosciences Announces Second Quarter 2019 Results

Jul 24, 2019 7:30am EDT

ProMIS Neurosciences Announces Results of Annual Meeting of Shareholders

Jul 18, 2019 3:00pm EDT

ProMIS Neurosciences Highlights Data for PMN310 at AAIC 2019

  • arrow_back
  • 1…
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • …19
  • arrow_forward
  • Email Alerts
  • Contacts
Facebook Linkedin Spotify Twitter
©2023 ProMIS Neurosciences, Inc. All Rights Reserved.
Disclaimer Sitemap Cookie Policy Privacy Policy